AGP Picks
View all

European Global Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on European Global Times.

Press releases published on July 24, 2026

NEZGLYAL® (leriglitazone) receives a positive CHMP opinion for the treatment of cerebral Adrenoleukodystrophy (cALD), a rare neurodegenerative disease
ArcelorMittal announces the publication of its second quarter 2026 sell-side analyst consensus figures
Robin Energy Announces Pricing of $3.0 Million Public Offering of Common Stock
NewAmsterdam Pharma and Menarini Group Receive Positive CHMP Opinion Recommending Marketing Authorization for Ubeslo® (Obicetrapib Monotherapy) and Evlarco® (Obicetrapib Plus Ezetimibe Fixed-Dose Combination)
SEA Index® extends CO₂ certification to the whole recreational yachting sector
Persica Pharmaceuticals presents new analyses of microbiology assay sensitivity and intradiscal antibiotic exposure response in chronic Low Back Pain at ASPN 2026 Annual Conference
Costamare Inc. Sets the Date for Its Second Quarter 2026 Results Release
Einride to Host First Half 2026 Earnings Conference Call on August 18, 2026
Nova Minerals Highlights Strategic Alignment with U.S. Defense Supply Chain Priorities Under White House Executive Order
A.I.S. Resources Unveils New Website and Corporate Presentation
DHT Holdings, Inc. Announces Fleet Update
Stella Maris, a historic palace, reopens in the Italian seaside town of Montesilvano as the new hub of University d'Annunzio (Chieti/Pescara) Healthy Campus, bringing a landmark of twentieth-century architecture back into public life
Luxphy Debuts Performance-Based Profit Recovery Service for Mid-Market Ecommerce Following $1.2M Pilot
RIB Achieves Dual Milestone: Industry-Led Product Enhancements and Public-Sector ERP Recognition
EXEL Industries: Q3 2025–2026 revenue -18.7%
EXEL Industries : Chiffre d’affaires 3e trimestre 2025–2026 - 18,7 %
Press Release: Sanofi announces decision not to submit amlitelimab in atopic dermatitis for global regulatory reviews
Communiqué de presse: Sanofi annonce sa décision de ne pas soumettre l’amlitélimab dans la dermatite atopique à des évaluations réglementaires mondiales
ISS announces conclusion of contract
ISS expands partnership with global energy technology company

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

European Global Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.